Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jan 23, 2013 (14 years ago)

Crest PRO-HEALTH CPC Antigingivitis/Antiplaque Oral Rinse

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Cross Contamination with Other Products: Product was mixed with another type of mouth wash.

Cause type: Cross-contamination

Traces of another drug - most often penicillin - got into the product from shared equipment or facilities. Even trace penicillin can trigger a severe allergic reaction in someone who was never meant to receive it. All cross-contamination recalls.

What was recalled

Crest PRO-HEALTH CPC Antigingivitis/Antiplaque Oral Rinse, 250 mL (8.4 fl oz),Dist. by Procter & Gamble, Cincinnati, OH 45202 NDC 37000-452-02

Affected NDC 37000-0452-02

Compare with the code on your package — it is the most precise check available.

Recalling firm
Procter & Gamble Hair Care Llc
NDC code
37000-452-02
Origin
IA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-167-2013 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other cross-contamination recalls from 2013

All cross-contamination recalls
Class II · Moderate risk

Tacrolimus Capsules

Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin

Terminated Cross-contamination Sandoz Incorporated NDC 0781-2102-01 D-383-2014
Class II · Moderate risk

Ropinirole

Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.

Terminated Cross-contamination Sandoz, Inc NDC 0781-5780-92 D-66458-1